Cited by 2,196Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record.

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Open access

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications

DOI 10.1006/bbrc.1995.2437

Open this paper in CoChat — free account

Abstract

The effects of anadamide, 2-arachidonoylglycerol and related compounds on the specific binding of a radiolabeled cannabinoid receptor ligand,[3H]CP55940, to synaptosomal membranes were examined. Anandamide, an endogenous cannabinoid receptor ligand, reduced the specific binding of [3H]CP55940 to synaptosomal membranes in a dose-dependent manner: the Ki value was 89 nM. 2-Arachidonoylglycerol was also shown to bind appreciably to the cannabinoid receptor in competitive inhibition experiments. The apparent binding affinity was markedly increased when the binding assay was carried out in the presence of the esterase inhibitor DFP or at 0 degrees C. Free arachidonic acid and N-palmitoylethanolamine were almost inactive in terms of binding to the cannabinoid receptor in synaptosomal membranes. 2-Arachidonoylglycerol may be an endogenous cannabinoid receptor ligand in the brain.

Integrity signals

Registry

Crossref · 10.1006/bbrc.1995.2437

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–500 of 1,009

Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids
Gammon, C. M., Freeman, G. M., Xie, W., Petersen, S. L., & Wetsel, W. C. (2005) · Endocrinology · doi:10.1210/en.2004-1672 · Cited by 126
Activating Parabrachial Cannabinoid CB 1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats
DiPatrizio, N. V., & Simansky, K. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1171-08.2008 · Cited by 129
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues
Fezza, F., Bisogno, T., Minassi, A., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02341-4 · Cited by 125
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B. R., & Razdan, R. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.009 · Cited by 124
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
Chung, Y. C., Bok, E., Huh, S. H., Park, J., Yoon, S., Kim, S. R., Kim, Y., Maeng, S., Park, S. H., & Jin, B. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102435 · Cited by 123
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
McAllister, S. D., Soroceanu, L., & Desprez, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9608-y · Cited by 144
Endocannabinoid signaling and food addiction
D’Addario, C., Bonaventura, M. V. M. D., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, R., Cifani, C., & Maccarrone, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.008 · Cited by 124
Cannabinoids: Medical implications
Schrot, R. J., & Hubbard, J. R. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1145794 · Cited by 135
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 129
2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism
Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., & Sugiura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301359200 · Cited by 125
Self-citation
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
Carlo, G. D., & Izzo, A. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.39 · Cited by 136
Lipid metabolism in astrocytic structure and function
Lee, J. A., Hall, B., Allsop, J., Alqarni, R., & Allen, S. P. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.07.017 · Cited by 116
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 137
Identification of the CB1 Cannabinoid Receptor and Fatty Acid Amide Hydrolase (FAAH) in the Human Placenta
Park, B., Gibbons, H. M., Mitchell, M. D., & Glassa, M. (2003) · Placenta · doi:10.1053/plac.2002.0926 · Cited by 122
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice
Basavarajappa, B. S., Yalamanchili, R., Cravatt, B. F., Cooper, T. B., & Hungund, B. L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.005 · Cited by 121
Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 120
Arvanil, anandamide and N‐arachidonoyl‐dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret
Sharkey, K. A., Cristino, L., Oland, L. D., Sickle, M. D. V., Starowicz, K., Pittman, Q. J., Guglielmotti, V., Davison, J. S., & Marzo, V. D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05521.x · Cited by 124
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways
Gómez, O., Sanchez‐Rodriguez, A., Le, M., Sanchez‐Caro, C., Molina‐Holgado, F., & Molina‐Holgado, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01414.x · Cited by 120
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain
Hanus, L. O., Avraham, Y., Ben‐Shushan, D., Zolotarev, O., Berry, E. M., & Mechoulam, R. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03046-4 · Cited by 120
Comparative biology of the endocannabinoid system
Salzet, M., Breton, C., Bisogno, T., & Marzo, V. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01550.x · Cited by 119
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
del Río, C., Millán, E., García, V., Appendino, G., DeMesa, J., & Muñóz, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.022 · Cited by 126
Calcium-independent Phospholipases in the Heart: Mediators of Cellular Signaling, Bioenergetics, and Ischemia-induced Electrophysiologic Dysfunction
Cedars, A. M., Jenkins, C. M., Mancuso, D. J., & Gross, R. W. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181a15e77 · Cited by 120
Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00589.x · Cited by 125
Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120
Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.014 · Cited by 118
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Bedse, G., Bluett, R. J., Patrick, T. A., Romness, N. K., Gaulden, A. D., Kingsley, P. J., Plath, N., Marnett, L. J., & Patel, S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0141-7 · Cited by 121
Human Platelets and Polymorphonuclear Leukocytes Synthesize Oxygenated Derivatives of Arachidonylethanolamide (Anandamide): Their Affinities for Cannabinoid Receptors and Pathways of Inactivation
Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Endocannabinoids and cannabinoid receptor genetics
Onaivi, E. S., Leonard, C. M., Ishiguro, H., Zhang, P. W., Lin, Z., Akinshola, B. E., & Uhl, G. R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00007-2 · Cited by 119
Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice
Ramesh, D., Ross, G. R., Schlosburg, J. E., Owens, R. A., Abdullah, R. A., Kinsey, S. G., Long, J. Z., Nomura, D. K., Sim‐Selley, L. J., Cravatt, B. F., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181370 · Cited by 123
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119
Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain
Leishman, E., Mackie, K., Luquet, S. H., & Bradshaw, H. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.003 · Cited by 118
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
King, A. R., Dotsey, E. Y., Lodola, A., Jung, K., Ghomian, A., Qiu, Y., Fu, J., Mor, M., & Piomelli, D. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.09.012 · Cited by 117
Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
Watson, J. E., Kim, J. S., & Das, A. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106337 · Cited by 117
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Leo, L. M., & Abood, M. E. (2021) · Molecules · doi:10.3390/molecules26175413 · Cited by 121
Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons
Basavarajappa, B. S., Saito, M., Cooper, T. B., & Hungund, B. L. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01557-7 · Cited by 115
Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled study
Esfandyari, T., Camilleri, M., Ferber, I., Burton, D. D., Baxter, K. L., & Zinsmeister, A. R. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00834.x · Cited by 117
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21
Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodríguez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 115
Activation of the endocannabinoid system by organophosphorus nerve agents
Nomura, D. K., Blankman, J. L., Simon, G. M., Fujioka, K., Issa, R. S., Ward, A. M., Cravatt, B. F., & Casida, J. E. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.86 · Cited by 112
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Marzo, V. D., Piscitelli, F., & Mechoulam, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_4 · Cited by 121
Cannabinoids: A new hope for breast cancer therapy?
Caffarel, M. M., Andradas, C., Pérez-Gómez, E., Guzmán, M., & Sánchez, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.005 · Cited by 119
Effects of Cannabinoids on Preimplantation Mouse Embryo Development and Implantation are Mediated by Brain-Type Cannabinoid Receptors1
Paria, B. C., Ma, W., Andrenyak, D. M., Schmid, P. C., Schmid, H. H. O., Moody, D. E., Deng, H., Makriyannis, A., & Dey, S. K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.6.1490 · Cited by 113
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
Edwards, D. A., Kim, J., & Alger, B. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00813.2005 · Cited by 113
A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Labar, G., Wouters, J., & Lambert, D. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859414 · Cited by 111
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain
Kehl, L. J., Hamamoto, D. T., Wacnik, P. W., Croft, D. L., Norsted, B. D., Wilcox, G. L., & Simone, D. A. (2003) · Pain · doi:10.1016/s0304-3959(02)00450-5 · Cited by 115
2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain
Nakane, S., Oka, S., Arai, S., Waku, K., Ishima, Y., Tokumura, A., & Sugiura, T. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00038-3 · Cited by 112
Self-citation
What we know and do not know about the cannabinoid receptor 2 (CB2)
Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M., & Dittel, B. N. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.002 · Cited by 117
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors
Lambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Cardiovascular actions of cannabinoids and their generation during shock
Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 111
Pharmacology of Cannabinoid CB 1 and CB 2 Receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · Cited by 112
Physical activity and the endocannabinoid system: an overview
Tantimonaco, M., Ceci, R., Sabatini, S., Catani, M. V., Rossi, A., Gasperi, V., & Maccarrone, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1575-6 · Cited by 112
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation
Viader, A., Ogasawara, D., Joslyn, C. M., Sánchez-Alavez, M., Mori, S., Nguyen, W., Conti, B., & Cravatt, B. F. (2016) · eLife · doi:10.7554/elife.12345 · Cited by 115
Endocannabinoids and Traumatic Brain Injury
Mechoulam, R., & Shohami, E. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8008-6 · Cited by 111
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
Sanson, M., Bueno, L. P., & Fioramonti, J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00819.x · Cited by 114
An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors
Savinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 110
Substituted 2-Thioxoimidazolidin-4-ones and Imidazolidine-2,4-diones as Fatty Acid Amide Hydrolase Inhibitors Templates
Muccioli, G. G., Fazio, N., Scriba, G. K. E., Poppitz, W., Cannata, F., Poupaert, J. H., Wouters, J., & Lambert, D. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050977k · Cited by 114
Functional neuroanatomy of the endocannabinoid system
Pazos, M. R., NUNEZ, E., Benito, C., Tolón, R. M., & Romero, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.030 · Cited by 112
Signaling via CNS cannabinoid receptors
Mackie, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.022 · Cited by 112
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
Hillard, C. J., & Campbell, W. B. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30024-9 · Cited by 109
The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific
Niyuhire, F., Varvel, S. A., Thorpe, A. J., Stokes, R. J., Wiley, J. L., & Lichtman, A. H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0650-6 · Cited by 110
A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists
Marzo, V. D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.01.010 · Cited by 115
Neurochemical basis of cannabis addiction
Maldonado, R. J., Berrendero, F., Ozaita, A., & Robledo, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.035 · Cited by 113
Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice
Oka, S., 潤一, 和., Ikeda, S., Shin, Y., Kishimoto, S., Gokoh, M., Nasui, M., & Sugiura, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8796 · Cited by 108
Self-citation
Cannabinoids modulate pain by multiple mechanisms of action
Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109
Cannabinoids and the Brain
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Gonçalves, E. C. D., Baldasso, G. M., Bicca, M. A., Paes, R. S., Capasso, R., & Dutra, R. C. (2020) · Molecules · doi:10.3390/molecules25071567 · Cited by 114
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 117
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Male–female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function
Gorzalka, B. B., Hill, M. N., & Chang, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.08.009 · Cited by 108
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
Oka, S., Ikeda, S., Kishimoto, S., Gokoh, M., Shin, Y., Waku, K., & Sugiura, T. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404252 · Cited by 109
Self-citation
Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons
Basavarajappa, B. S., Ninan, I., & Arancio, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05685.x · Cited by 108
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety
Bedse, G., Hartley, N. D., Neale, E., Gaulden, A. D., Patrick, T. A., Kingsley, P. J., Uddin, M. J., Plath, N., Marnett, L. J., & Patel, S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.002 · Cited by 108
Cannabinoids and Neuroprotection
Beltramo, M., Grundy, R. I., & Rabuffetti, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:029 · Cited by 109
FAAH and anandamide: is 2-AG really the odd one out?
Marzo, V. D., & Maccarrone, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.001 · Cited by 109
The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility
Karasu, T., Marczylo, T. H., Maccarrone, M., & Konje, J. C. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq058 · Cited by 105
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2018) · Antioxidants · doi:10.3390/antiox7070093 · Cited by 111
The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders
Maia, J. C., FONSECA, B. K. S., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa005 · Cited by 110
Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts
Ford, W. R., Honan, S. A., White, R., & Hiley, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704565 · Cited by 107
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Role of Cannabinoids in Multiple Sclerosis
Zajicek, J., & Apostu, V. I. (2011) · CNS Drugs · doi:10.2165/11539000-000000000-00000 · Cited by 106
The role of endocannabinoids in pain modulation
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 112
A Predominant Role for Inhibition of the Adenylate Cyclase/Protein Kinase A Pathway in ERK Activation by Cannabinoid Receptor 1 in N1E-115 Neuroblastoma Cells
Davis, M. I., Ronesi, J. A., & Lovinger, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305697200 · Cited by 112
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS
Fanelli, F., Lallo, V. D. D., Belluomo, I., IASIO, R. D., Baccini, M., Casadio, E., Gasparini, D. I., Colavita, M., Gambineri, A., Grossi, G., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m021378 · Cited by 105
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02655-5 · Cited by 104
Self-citation
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., Biasi, M. D., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 109
Cannabis-Based Medicines and Pain: A Review of Potential Synergistic and Entourage Effects
Anand, U., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021) · Pain Management · doi:10.2217/pmt-2020-0110 · Cited by 132
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 114
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141635 · Cited by 109
Marijuana: Respiratory Tract Effects
Owen, K. P., Sutter, M. E., & Albertson, T. E. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8374-y · Cited by 104
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 104
Anandamide as an intracellular messenger regulating ion channel activity
van der Stelt, M., & Marzo, V. D. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.007 · Cited by 102
Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice
Járai, Z., Wagner, J. A., Goparaju, S. K., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.679 · Cited by 102
Self-citation
Suppression of Interleukin-2 by the Putative Endogenous Cannabinoid 2-Arachidonyl-Glycerol Is Mediated through Down-regulation of the Nuclear Factor of Activated T Cells
Ouyang, Y., Hwang, S. G., Han, S. H., & Kaminski, N. E. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.676 · Cited by 101
Endocannabinoid system and pregnancy
Corrêa, F. M. D. A., Wolfson, M. L., Valchi, P., Aisemberg, J., & Franchi, A. M. (2016) · Reproduction · doi:10.1530/rep-16-0167 · Cited by 103
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo—A Randomized, Placebo-controlled, Double-blind Controlled Trial
Couch, D. G., Cook, H., Ortori, C. A., Barrett, D. A., Lund, J. N., & O’Sullivan, S. E. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz017 · Cited by 106
Endocannabinoids: A unique opportunity to develop multitarget analgesics
Maione, S., Costa, B., & Marzo, V. D. (2013) · Pain · doi:10.1016/j.pain.2013.03.023 · Cited by 104
Chemical stability of 2-arachidonylglycerol under biological conditions
Rouzer, C. A., Ghebreselasie, K., & Marnett, L. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00068-3 · Cited by 101
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Melis, M., Pillolla, G., Bisogno, T., Minassi, A., Petrosino, S., Perra, S., Muntoni, A. L., Lutz, B., Gessa, G. L., & Marsicano, G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.010 · Cited by 101

Authors: Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K.
Affiliations: Teikyo University (JP)
ORCID: Yamashita, A.
Venue: Biochemical and Biophysical Research Communications
Publisher: Elsevier BV
Published: 1995-10
Volume: 215
Issue: 1
Pages: 89-97
ISSN: 0006-291X (ISSN-L)
DOI: 10.1006/bbrc.1995.2437
OpenAlex: W2085741941
Cited by: 2,196
References: 0
Citations by year: 2026: 22 · 2025: 61 · 2024: 68 · 2023: 63 · 2022: 59 · 2021: 113 · 2020: 97 · 2019: 68 · 2018: 77 · 2017: 74 · 2016: 79 · 2015: 84 · 2014: 87 · 2013: 82 · 2012: 95
FWCI: 14.31
Type: journal article
Language: en
Open access: green
teikyo-u.repo.nii.ac.jp
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical and Biophysical Research Communications (publishedVersion)
PubMed (publishedVersion)
Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: 2-arachidonoylglycerol, anandamide, endocannabinoid system, cannabinoid receptors, synaptosomal membranes, competitive inhibition, esterase inhibition, DFP, arachidonic acid, N-palmitoylethanolamine, brain
MeSH terms: Animals, Arachidonic Acids, Binding, Competitive, Brain, Cannabinoids, Cyclohexanols, Dose-Response Relationship, Drug, Glycerides, Lipase, Male, Receptors, Drug, Synaptic Membranes, Tritium, Rats, Wistar, Receptors, Cannabinoid, Rats, Polyunsaturated Alkamides, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks